{
    "Trade/Device Name(s)": [
        "Immunalysis Amphetamine Urine Enzyme Immunoassay",
        "Immunalysis Amphetamine Urine Calibrator",
        "Immunalysis Amphetamine Urine Control Set",
        "Immunalysis Amphetamine Urine Controls",
        "Immunalysis Amphetamine Urine Calibrators"
    ],
    "Submitter Information": "Immunalysis Corporation",
    "510(k) Number": "K143500",
    "Predicate Device Reference 510(k) Number(s)": [
        "K062077"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "DLJ",
        "LAS"
    ],
    "Summary Letter Date": "December 9, 2014",
    "Summary Letter Received Date": "December 10, 2014",
    "Submission Date": "January 27, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3200",
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system",
        "Calibrators, Drug Specific",
        "Drug Specific Control Materials"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Beckman Coulter AU 400e"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Immunalysis Amphetamine Urine Enzyme Immunoassay, calibrators, and controls for qualitative and semi-quantitative determination of amphetamine in urine using homogeneous enzyme immunoassay technology.",
    "Indications for Use Summary": "Qualitative and semi-quantitative analysis of amphetamine in human urine with automated clinical chemistry analyzers for prescription use; preliminary screening test with confirmatory method required.",
    "fda_folder": "Toxicology"
}